01 1The Division of Cancer Treatment and Diagnosis
01 1SANGIVAMYCIN HCL (NSC 143648) AS PREPARED BY THE FREDERICK CANCER RES.
01 1U.S.A
01 1Inactive
01 1Blank
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4417
Submission : 1982-01-27
Status : Inactive
Type : II
20
National Cancer Institute, based in U.S.A, is a pharmaceutical company.
One of their notable products is SANGIVAMYCIN HCL (NSC 143648) AS PREPARED BY THE FREDERICK CANCER RES., with a corresponding US DMF Number 4417.
Remarkably, this DMF maintains an Inactive status since its submission on January 27, 1982, highlighting commitment to regulatory compliance.
